Engineering Director, Prenuvo

The medical benefits of approaching these diseases proactively, as opposed to reactively, are substantial. Customers will be able to catch warning signs early, meaning treatment is likely to be less invasive, with a higher success rate. Unfortunately North America, like many regions, has yet to make substantial investments in preventative healthcare. This just makes companies like Prenuvo, and the VCs who fund them, increasingly necessary.

This funding, however has been substantial, and having closed multiple funding rounds, the company is now setting its sights on Europe. The opening of its first London clinic marks the start of that expansion, brining Prenuvo's full-body MRI services to a new market with high demand for early detection and diagnostic imaging. With plans to evaluate additional cities across the continent, the company is in a position to grow its international presence.